» Articles » PMID: 30888254

Rapid Transition from Methadone to Buprenorphine Using Naltrexone-induced Withdrawal: A Case Report

Overview
Journal Subst Abus
Publisher Sage Publications
Date 2019 Mar 20
PMID 30888254
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Patients taking methadone for opioid use disorder may desire transition to buprenorphine for a number of reasons. However, the current recommended approach for this transition generally takes weeks to months as an outpatient, causing considerable discomfort to the patient and a heightened risk of relapse during the transition period. We describe the case of a patient on methadone maintenance who was rapidly transitioned to buprenorphine because of her desire to not return to her methadone clinic. In order to rapidly transition the patient from methadone to buprenorphine, naltrexone was administered to precipitate acute opioid withdrawal, which was followed soon after by buprenorphine induction. Rapid transition from methadone maintenance to buprenorphine can be accomplished in inpatients by precipitating acute withdrawal with naltrexone, providing an effective alternative for patients who cannot tolerate the typical protracted methadone taper required prior to buprenorphine induction as an outpatient.

Citing Articles

Buprenorphine Pharmacodynamics: A Bridge to Understanding Buprenorphine Clinical Benefits.

Davis M Drugs. 2025; 85(2):215-230.

PMID: 39873915 DOI: 10.1007/s40265-024-02128-y.


Predictors of concurrent heroin use among patients on opioid maintenance treatment in France: a multilevel study over 11 years.

Janssen E, Vuolo M, Spilka S, Airagnes G Harm Reduct J. 2024; 21(1):15.

PMID: 38243253 PMC: 10799399. DOI: 10.1186/s12954-024-00934-x.


A Guide to Expanding the Use of Buprenorphine Beyond Standard Initiations for Opioid Use Disorder.

Miller J, Brooks M, Wurzel K, Cox E, Wurzel 3rd J Drugs R D. 2023; 23(4):339-362.

PMID: 37938531 PMC: 10676346. DOI: 10.1007/s40268-023-00443-5.


Buprenorphine initiation strategies for opioid use disorder and pain management: A systematic review.

Spreen L, Dittmar E, Quirk K, Smith M Pharmacotherapy. 2022; 42(5):411-427.

PMID: 35302671 PMC: 9310825. DOI: 10.1002/phar.2676.


Transition From Full Mu Opioid Agonists to Buprenorphine in Opioid Dependent Patients-A Critical Review.

Soyka M Front Pharmacol. 2021; 12:718811.

PMID: 34887748 PMC: 8650116. DOI: 10.3389/fphar.2021.718811.


References
1.
Levin F, FISCHMAN M, Connerney I, Foltin R . A protocol to switch high-dose, methadone-maintained subjects to buprenorphine. Am J Addict. 1997; 6(2):105-16. DOI: 10.3109/10550499709137021. View

2.
Collins E, Kleber H, Whittington R, Heitler N . Anesthesia-assisted vs buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction: a randomized trial. JAMA. 2005; 294(8):903-13. DOI: 10.1001/jama.294.8.903. View

3.
Mittal L . Buprenorphine for the treatment of opioid dependence in pregnancy. J Perinat Neonatal Nurs. 2014; 28(3):178-84. DOI: 10.1097/JPN.0000000000000044. View

4.
Fishman M, Wu L, Woody G . Buprenorphine for prescription opioid addiction in a patient with depression and alcohol dependence. Am J Psychiatry. 2011; 168(7):675-9. PMC: 3178807. DOI: 10.1176/appi.ajp.2010.10060879. View

5.
Calsyn D, Malcy J, Saxon A . Slow tapering from methadone maintenance in a program encouraging indefinite maintenance. J Subst Abuse Treat. 2006; 30(2):159-63. DOI: 10.1016/j.jsat.2005.11.007. View